Hematology Analyzer
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Points of contact
-
- CDRH Acquisition Liaison cdhracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration seeks to purchase a hematology analyzer for use in a research laboratory to provide rapid, accurate measurements of complete blood cell counts in both human and animal blood samples. Solicitation is estimated to release on May 1, 2027, with award targeted for July 1, 2027. This new requirement carries no set-aside designation.
The estimated award value ranges from $25,000 to $250,000. Performance will occur at an FDA research laboratory location. Inquiries should be directed to the FDA's Center for Devices and Radiological Health acquisitions mailbox at cdhracquisitions@fda.hhs.gov.
Forecast text
We seek to purchase a hematology analyzer to be used in a research laboratory to provide rapid, accurate measurements of complete blood cell counts (CBC) in both human and animal blood samples
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast